Finance

Beta
Lists
CAMP:NASDAQ
CAMP4 Therapeutics Corp
US$4,45
0,00%
(0,00) 1D
14 ກ.ລ., 16 ໂມງ 0 ນາທີ 01 ວິນາທີ GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CAMP...
Mkt. cap
໒໓໑,໐໗ ລ້ານ
Avg. vol.
໒໗໐,໖໐ ພັນ
Volume
໕,໐໐
52-wk high
US$7,75
52-wk low
US$1,32
EPS
US$-2,24
Shares outstanding
໕໑,໙໓ ລ້ານ
No. of employees
໔໘
Mkt. cap
໒໓໑,໐໗ ລ້ານ
Avg. vol.
໒໗໐,໖໐ ພັນ
Volume
໕,໐໐
52-wk high
US$7,75
52-wk low
US$1,32
EPS
US$-2,24
Shares outstanding
໕໑,໙໓ ລ້ານ
No. of employees
໔໘
News stories
From sources across the web
About CAMP4 Therapeutics Corp
CEO-
Employees48
Founded2015
Headquarters-
SectorBiotechnology
Analyst ratings
Based on 6 analysts giving stock ratings to CAMP in the past 3 months
Strong buy
Buy
6
Hold
0
Sell
0
12-month forecast
Based on 6 Wall Street analysts offering 12 month price targets for CAMP in the last 3 months.
Highest
Current US$4,45
US$12,00 (+169,66%)
Average
US$8,50 (+91,01%)
Lowest
US$6,50 (+46,07%)
Analyst
Recommendation
Action
Price target
Projected
Date
Myles Minter
William Blair
Buy
Reiterated
-
-
06/25/2026
Anupam Rama
J.P. Morgan
Buy
Upgraded
US$9,00
+102,2%
06/22/2026
Keay Nakae
Chardan Capital
Buy
Initiated
US$6,50
+46,1%
06/10/2026
Edward Tenthoff
Piper Sandler
Buy
Reiterated
US$12,00
+169,7%
05/15/2026
Yun Zhong
Wedbush
Buy
Maintained
US$8,00
+79,8%
05/08/2026
Steven Seedhouse
Cantor Fitzgerald
Buy
Maintained
US$7,00
+57,3%
05/08/2026
Seema Sheoran
Rodman & Renshaw
Buy
Initiated
US$7,00
+57,3%
04/14/2026
Mani Foroohar
Leerink Partners
Buy
Maintained
US$9,00
+102,2%
04/02/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
ມິ.ຖ. 2025
ກ.ຍ. 2025
ທ.ວ. 2025
ມ.ນ. 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
-
-
-
Operating expense
-
-
-
-
Total operating expenses
-
-
-
-
Operating income
-
-
-
-
Other non operating income
-
-
-
-
EBT including unusual items
-
-
-
-
EBT excluding unusual items
-
-
-
-
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-
-
-
-
Net profit margin
-840,81%
-1.899,25%
-11.575,86%
-1.416,62%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more